SCHEMBL6983075

SCHEMBL6983075

COC(=O)/C=C/c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
CYP2D6 P10635 1/20 0.56
MAPT P10636 4/20 0.50
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 3/20 0.50
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
HSP90AA1 P07900 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
NLRP1 Q9C000 1/20 0.50
HSD17B10 Q99714 2/20 0.47
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983081 1.00 CYP1A2 (0.56) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL9330267 0.91 CYP1A2 (0.50) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL31406407 0.86 ALDH1A1 (0.50) CYP1A2MAPTKMT2AALDH1A1MEN1
SCHEMBL16971052 0.86 ALDH1A1 (0.50) CYP1A2MAPTKMT2AALDH1A1MEN1
SCHEMBL9756703 0.85 CYP1A2 (0.53) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL9756705 0.85 CYP1A2 (0.53) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL6809200 0.85 CYP1A2 (0.53) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL6639628 0.85 CYP1A2 (0.53) CYP1A2CYP2D6MAPTKMT2AALDH1A1
SCHEMBL6981756 0.84 TLR9 (0.53) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL9551020 0.84 MAPT (0.49) CYP1A2CYP2D6MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed
US-5237089-A Herbicides BASF AKTIENGESELLSCHAFT (DE) 1993-08-17 US disclosed
US-5062884-A Herbicides BASF AKTIENGESELLSCHAFT (DE) 1991-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 CYP1A2 380/4885CYP2D6 947/4885MAPT 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.